179 related articles for article (PubMed ID: 24317794)
1. Common variation at PPARGC1A/B and change in body composition and metabolic traits following preventive interventions: the Diabetes Prevention Program.
Franks PW; Christophi CA; Jablonski KA; Billings LK; Delahanty LM; Horton ES; Knowler WC; Florez JC;
Diabetologia; 2014 Mar; 57(3):485-90. PubMed ID: 24317794
[TBL] [Abstract][Full Text] [Related]
2. Glucose levels and genetic variants across transcriptional pathways: interaction effects with BMI.
Povel CM; Feskens EJ; Imholz S; Blaak EE; Boer JM; Dollé ME
Int J Obes (Lond); 2010 May; 34(5):840-5. PubMed ID: 20125101
[TBL] [Abstract][Full Text] [Related]
3. The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program.
Franks PW; Jablonski KA; Delahanty L; Hanson RL; Kahn SE; Altshuler D; Knowler WC; Florez JC;
Diabetologia; 2007 Dec; 50(12):2451-60. PubMed ID: 17898990
[TBL] [Abstract][Full Text] [Related]
4. PPARGC1A rs3736265 G>A polymorphism is associated with decreased risk of type 2 diabetes mellitus and fasting plasma glucose level.
Zhu L; Huang Q; Xie Z; Kang M; Ding H; Chen B; Chen Y; Liu C; Wang Y; Tang W
Oncotarget; 2017 Jun; 8(23):37308-37320. PubMed ID: 28418876
[TBL] [Abstract][Full Text] [Related]
5. Evidence for interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser polymorphisms in determining type 2 diabetes intermediate phenotypes in overweight subjects.
Ruchat SM; Weisnagel SJ; Vohl MC; Rankinen T; Bouchard C; Pérusse L
Exp Clin Endocrinol Diabetes; 2009 Oct; 117(9):455-9. PubMed ID: 19536736
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes.
Barroso I; Luan J; Sandhu MS; Franks PW; Crowley V; Schafer AJ; O'Rahilly S; Wareham NJ
Diabetologia; 2006 Mar; 49(3):501-5. PubMed ID: 16435105
[TBL] [Abstract][Full Text] [Related]
7. PPARGC1A sequence variation and cardiovascular risk-factor levels: a study of the main genetic effects and gene x environment interactions in children from the European Youth Heart Study.
Brito EC; Vimaleswaran KS; Brage S; Andersen LB; Sardinha LB; Wareham NJ; Ekelund U; Loos RJ; Franks PW
Diabetologia; 2009 Apr; 52(4):609-13. PubMed ID: 19183932
[TBL] [Abstract][Full Text] [Related]
8. Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention.
Stefan N; Thamer C; Staiger H; Machicao F; Machann J; Schick F; Venter C; Niess A; Laakso M; Fritsche A; Häring HU
J Clin Endocrinol Metab; 2007 May; 92(5):1827-33. PubMed ID: 17327385
[TBL] [Abstract][Full Text] [Related]
9. Haplotypes of PPARGC1A are associated with glucose tolerance, body mass index and insulin sensitivity in offspring of patients with type 2 diabetes.
Pihlajamäki J; Kinnunen M; Ruotsalainen E; Salmenniemi U; Vauhkonen I; Kuulasmaa T; Kainulainen S; Laakso M
Diabetologia; 2005 Jul; 48(7):1331-4. PubMed ID: 15912394
[TBL] [Abstract][Full Text] [Related]
10. Effect of polymorphisms in the PPARGC1A gene on body fat in Asian Indians.
Vimaleswaran KS; Radha V; Anjana M; Deepa R; Ghosh S; Majumder PP; Rao MR; Mohan V
Int J Obes (Lond); 2006 Jun; 30(6):884-91. PubMed ID: 16446747
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the association between the PPARGC1A genetic polymorphisms and type 2 diabetes in Han Chinese population.
Zhu S; Liu Y; Wang X; Wu X; Zhu X; Li J; Ma J; Gu HF; Liu Y
Diabetes Res Clin Pract; 2009 Dec; 86(3):168-72. PubMed ID: 19828207
[TBL] [Abstract][Full Text] [Related]
12. An exonic peroxisome proliferator-activated receptor-γ coactivator-1α variation may mediate the resting energy expenditure through a potential regulatory role on important gene expression in this pathway.
Mirzaei K; Hossein-nezhad A; Emamgholipour S; Ansar H; Khosrofar M; Tootee A; Alatab S
J Nutrigenet Nutrigenomics; 2012; 5(2):59-71. PubMed ID: 22652814
[TBL] [Abstract][Full Text] [Related]
13. Variation at the melanocortin 4 receptor gene and response to weight-loss interventions in the diabetes prevention program.
Pan Q; Delahanty LM; Jablonski KA; Knowler WC; Kahn SE; Florez JC; Franks PW;
Obesity (Silver Spring); 2013 Sep; 21(9):E520-6. PubMed ID: 23512951
[TBL] [Abstract][Full Text] [Related]
14. [Association study between PPARGC1A Thr394Thr/ Gly482Ser polymorphisms and type 2 diabetes].
Su Y; Peng SB; Li ZQ; Huang QY
Yi Chuan; 2008 Mar; 30(3):304-8. PubMed ID: 18331997
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha promoter polymorphisms are associated with early-onset type 2 diabetes mellitus in the Korean population.
Kim JH; Shin HD; Park BL; Cho YM; Kim SY; Lee HK; Park KS
Diabetologia; 2005 Jul; 48(7):1323-30. PubMed ID: 15937669
[TBL] [Abstract][Full Text] [Related]
16. Variants in the PPARGC1A Gene may Influence the Effect of Fat Intake on Resting Metabolic Rate in Obese Women.
Moradi S; Mirzaei K; Maghbooli Z; Abdurahman AA; Keshavarz SA
Lipids; 2018 Mar; 53(3):291-300. PubMed ID: 29663401
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation in the peroxisome proliferator-activated receptor (PPAR) and peroxisome proliferator-activated receptor gamma co-activator 1 (PGC1) gene families and type 2 diabetes.
Villegas R; Williams SM; Gao YT; Long J; Shi J; Cai H; Li H; Chen CC; Tai ES; ; Hu F; Cai Q; Zheng W; Shu XO
Ann Hum Genet; 2014 Jan; 78(1):23-32. PubMed ID: 24359475
[TBL] [Abstract][Full Text] [Related]
18. Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer.
Wirtenberger M; Tchatchou S; Hemminki K; Schmutzhard J; Sutter C; Schmutzler RK; Meindl A; Wappenschmidt B; Kiechle M; Arnold N; Weber BH; Niederacher D; Bartram CR; Burwinkel B
Carcinogenesis; 2006 Nov; 27(11):2201-8. PubMed ID: 16704985
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion.
Ling C; Del Guerra S; Lupi R; Rönn T; Granhall C; Luthman H; Masiello P; Marchetti P; Groop L; Del Prato S
Diabetologia; 2008 Apr; 51(4):615-22. PubMed ID: 18270681
[TBL] [Abstract][Full Text] [Related]
20. The Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) is associated with type 2 diabetes in Tunisian population.
Jemaa Z; Kallel A; Sleimi C; Mahjoubi I; Feki M; Ftouhi B; Slimane H; Jemaa R; Kaabachi N
Diabetes Metab Syndr; 2015; 9(4):316-9. PubMed ID: 25470625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
